People · Operator
Named in public records as an officer, director or promoter · active 2013–2024 · Pharmaceuticals, Biotechnology, Pharma, Healthtech, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Eliem Therapeutics, Inc. | — | Pharmaceuticals | Series D+ | $253.2M | $1.3B | 2020 |
| AmbAgon Therapeutics Inc. | — | Biotechnology | Series C | $55.4M | $35.9M | 2020 |
| Athenen Therapeutics, Inc. | — | Pharmaceuticals | Series A | $12.0M | $371.7M | 2019 |
| Rodin Therapeutics, Inc. | — | Pharma | Series A | $10.8M | $335.3M | 2017 |
| Adeo Health Science, Inc. | — | Healthtech | Seed | $5.4M | $85.4M | 2017 |
| Clear Demand, Inc. | — | Other | Pre-Seed | $200K | $4.6M | 2013 |
Adam Rosenberg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Adam Rosenberg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ANDREW LEVIN | 2 | 17 |
| Joshua Resnick | 1 | 12 |
| Bruce Booth | 1 | 12 |
| Peter Kolchinsky | 1 | 8 |
| James Schneider | 1 | 5 |
| Stephen Thomas | 1 | 5 |
| Liam Ratcliffe | 1 | 4 |
| Margarita Chavez | 1 | 4 |
| Janwillem Naesens | 1 | 3 |
| Julio Vega | 1 | 3 |
| Erin Lavelle | 1 | 3 |
| Brent Lippman | 1 | 2 |
| Robert Azelby | 1 | 2 |
| Aoife Brennan | 1 | 2 |
| Peter Dudek | 1 | 2 |
| David-Alexandre Gros | 1 | 2 |
| SAMANTHA SINGER | 1 | 2 |
| Sari Epstein | 1 | 2 |
| Sarah Reed | 1 | 2 |
| Aaron Bergener | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.